-
1 Comment
Hunan Jiudian Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 52.4% above its 200 day moving average.
From a valuation standpoint, the stock is 26.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.1.
Hunan Jiudian Pharmaceutical Co., Ltd's total revenue sank by 0.4% to $264M since the same quarter in the previous year.
Its net income has increased by 30.0% to $22M since the same quarter in the previous year.
Finally, its free cash flow grew by 38.9% to $46M since the same quarter in the previous year.
Based on the above factors, Hunan Jiudian Pharmaceutical Co., Ltd gets an overall score of 4/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE1000034Z6 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Market Cap | 8B |
|---|---|
| PE Ratio | 17.6 |
| Target Price | 29 |
| Beta | 0.49 |
| Dividend Yield | 1.9% |
Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. Its leading products are loxoprofen sodium gel plaster and hydrochloric acid. The company offers its products in the anti-inflammatory and analgesic, anti-infective, anti-allergic, digestive system, cardiovascular and cerebrovascular, gynecological drugs, supplements, and other fields. The company was founded in 2001 and is based in Changsha, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300705.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
